Item 1A.  Risk Factors
There have been no material changes in our risk factors disclosed in Part 1, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.
Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.
Issuer Purchases of Equity Securities
Total Number
of Shares Purchased (1)
Average Price
Paid per Share (2)
Total Number of
Shares Purchased
as Part of the
Publicly
Announced
Common Stock Repurchase Plan (1)
Maximum Approximate Dollar Value
of Shares that
may yet be
Purchased under
the Common Stock
Repurchase Plan (1) (2)
Period
October 1 to 31, 2025
519,252 
$
284.20 
519,252 
$
1,286,258,009 
November 1 to 30, 2025
674,012 
$
256.23 
674,012 
$
1,113,558,970 
December 1 to 31, 2025
741,860 
$
262.74 
741,860 
$
918,641,111 
Total
1,935,124 
1,935,124

(1)
The Company received the Board of Directors' approval in November 2022 to repurchase $5 billion of its common stock, as reflected in the table above. In January 2026, the Company received the Board of Directors' approval to repurchase $6 billion of its common stock, which replaces in its entirety the previous 2022 authorization.
(2)
Inclusive of the impact of the one-percent excise tax under the Inflation Reduction Act of 2022.
There is no expiration date for the common stock repurchase authorization.
Item 5.  Other Information
(c) 
During the fiscal quarter ended December 31, 2025, none of the Company’s directors or executive officers 
adopted
 or 
terminated
 any contract